Skip to Main content Skip to Navigation
Journal articles

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Nicolas Girard F. Mornex J.-Y. Douillard Nadine Bossard 1 E. Quoix V. Beckendorf D. Grunenwald E. Amour B. Milleron
1 Biostatistiques santé
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-00539239
Contributor : Stéphane Delmotte Connect in order to contact the contributor
Submitted on : Wednesday, November 24, 2010 - 2:41:07 PM
Last modification on : Tuesday, July 20, 2021 - 5:20:06 PM

Identifiers

  • HAL Id : hal-00539239, version 1

Collections

Citation

Nicolas Girard, F. Mornex, J.-Y. Douillard, Nadine Bossard, E. Quoix, et al.. Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial. Lung Cancer, Elsevier, 2010, 69(1), pp.86-93. ⟨hal-00539239⟩

Share

Metrics

Record views

180